We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Northern Venture Trust Plc | LSE:NVT | London | Ordinary Share | GB0006450703 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 57.50 | 56.00 | 59.00 | 57.50 | 57.50 | 57.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Trust,ex Ed,religious,charty | -9.13M | -9.92M | -0.0568 | -10.12 | 100.49M |
TIDMNVT
10 FEBRUARY 2023
NORTHERN VENTURE TRUST PLC
UNAUDITED NET ASSET VALUE AS AT 31 DECEMBER 2022
Northern Venture Trust PLC ("the Company") is a Venture Capital Trust ("VCT") launched in 1995 and advised by Mercia Fund Management Limited. The Company's objective is to provide high long-term tax-free returns to investors through a combination of dividend yield and capital growth, by investing in a portfolio of investments mainly comprising unquoted venture capital holdings. In order to maintain approval by HM Revenue & Customs as a VCT, the Company is required to comply on a continuing basis with the provisions of Section 274 of the Income Tax Act 2007.
The unaudited net asset value per ordinary share as at 31 December 2022 was 62.2 pence (30 September 2022 (unaudited) 63.5 pence).
The net asset value is stated before deducting the second interim dividend of 2.0 pence per share in respect of the eighteen month period ending 31 March 2023, which was paid to eligible shareholders on 13 January 2023.
For the purposes of calculating the net asset value per share, quoted investments are carried at bid price as at 31 December 2022 and unquoted investments are carried at fair value as at 31 December 2022 as determined by the directors.
New Investments:
During the three months ended 31 December 2022 three new venture capital investments were completed.
Amount invested Name of company Business activity GBP000 ------------------------ ------------------------------------------ --------- Turbine Simulated Cell Simulating cell reaction to the treatment Technologies Ltd of complex disease 1,433 Axis Spine Technologies Development of next generation spinal Ltd implants 955 Underwriting workbench solutions for insurers, reinsurers, and managing Send Technology Ltd general agents 974
In addition to the new investments above, GBP2,403,000 was invested in nine existing portfolio companies during the quarter.
There were no venture capital exits during the quarter.
The number of ordinary shares in issue at 31 December 2022 was 165,119,180. During the three months ended 31 December 2022 no shares were allotted and 2,004,747 shares were purchased for cancellation at an average price of 60.1 pence per share.
Enquiries:
Sarah Williams / James Sly, Mercia Fund Management Limited -- 0330 223 1430
Website: www.mercia.co.uk/vcts
Neither the contents of the Mercia Asset Management PLC website, nor the contents of any website accessible from hyperlinks on the Mercia Asset Management PLC website (or any other website), are incorporated into, or form part of, this announcement.
(END) Dow Jones Newswires
February 10, 2023 06:00 ET (11:00 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Northern Venture Chart |
1 Month Northern Venture Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions